Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

View:
Post by Danorrn on Mar 15, 2021 4:17pm

Nice uptick

Keep climbing.
Comment by Danorrn on Mar 15, 2021 5:08pm
SMIO is positive, MACD is positive and the trend is your friend. Up on the daily and weekly chart.
Comment by rico91 on Mar 15, 2021 5:56pm
As the clock ticks toward the last week of March, FOMO is going to become very strong and the more the SP rises, the stronger the FOMO will be! Ultimately the data will speak for its self. Rico
Comment by Mole101 on Mar 15, 2021 6:19pm
trades  From:  To:  Go 818,528 ($256,641) AGN.CN shares exchanged hands today. House  Bought  Sold  Net  House 080 National Bank Bought $76,954 Volume 243,500  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities